SCHEMBL2728564

SCHEMBL2728564

COc1ncnc(NS(=O)(=O)c2ccc(NC(C)=O)cc2)c1OC

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.69
ESR1 P03372 1/20 0.68
ALDH1A1 P00352 3/20 0.60
LMNA P02545 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
HTT P42858 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ALOX15 P16050 1/20 0.53
MAPK1 P28482 1/20 0.53
MAPT P10636 1/20 0.52
CYP19A1 P11511 1/20 0.51
IDO1 P14902 1/20 0.51
AKT1 P31749 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22686308 0.83 ESR1 (0.58) GAAESR1ALDH1A1LMNASMN1; SMN2
Sulfadoxine SCHEMBL29390814 0.81 ESR1 (1.00) ESR1ALDH1A1LMNASMN1; SMN2KDM4E
Sulfadoxine SCHEMBL41069 0.81 ESR1 (1.00) ESR1ALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL9007901 0.81 ESR1 (0.58) GAAESR1ALDH1A1SMN1; SMN2HTT
SCHEMBL21753107 0.81 ESR1 (0.76) ESR1LMNAKDM4ECYP19A1MEN1
SCHEMBL31548600 0.81 ESR1 (0.76) ESR1LMNAKDM4ECYP19A1MEN1
Sulfadoxine SCHEMBL28537335 0.80 ESR1 (0.97) ESR1ALDH1A1LMNASMN1; SMN2KDM4E
Sulfadoxine SCHEMBL28436237 0.80 ESR1 (0.97) ESR1ALDH1A1LMNASMN1; SMN2KDM4E
Sulfadoxine SCHEMBL28359083 0.80 ESR1 (0.97) ESR1ALDH1A1LMNASMN1; SMN2KDM4E
Sulfadoxine SCHEMBL27856131 0.80 ESR1 (0.97) ESR1ALDH1A1LMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106565615-A Preparation method of sulfadoxine derivative 重庆康乐制药有限公司 2017-04-19 CN disclosed
WO-2012058298-A1 BIOMARKERS OF REDUCED INSULIN ACTION MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2012-05-03 WO disclosed